Immunic, Inc. ( IMUX) - Stock Earnings
IMUX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -25.6 million USD | — USD |
| 2025Q4 | -19.3 million USD | — USD |
| 2026Q1 | -32.6 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
IMUX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -93.6 million USD | — USD |
| 2024 | -100.5 million USD | — USD |
| 2025 | -97.2 million USD | — USD |
| 2026 Est. | — | — |
IMUX
Price: $13.71
52 week price:
Earnings Per Share: -4.77 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 562646
Market Capitalization: 127.4 million